Literature DB >> 1930680

Osteocalcin: diagnostic methods and clinical applications.

M J Power1, P F Fottrell.   

Abstract

Osteocalcin is a small (Mr 5800), very interesting bone specific protein, synthesized by osteoblasts and measured in plasma as a biochemical indicator of bone formation. Many immunoassays for osteocalcin have been developed, including radio- and enzymoimmunoassays, with the use of monoclonal and polyclonal antibodies. These are used in many different clinical settings, including bone, kidney, and liver diseases. However, there is a wide range of published values for plasma osteocalcin concentrations in control and patient samples and this has hindered a more widespread adoption of osteocalcin measurement by clinicians. This review discusses how various immunoassays for osteocalcin may contribute to the wide variation of published values and suggests approaches for the development of standardized assays. For example, epitope specificity and immunoreactivity with multiple forms of osteocalcin and osteocalcin peptides in plasma are discussed. It also includes a recent update on interesting clinical applications of osteocalcin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930680     DOI: 10.3109/10408369109106867

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  18 in total

1.  BMD and Serum Intact Osteocalcin in Postmenopausal Osteoporosis Women.

Authors:  Vanita R Jagtap; Jayashri V Ganu; Nitin S Nagane
Journal:  Indian J Clin Biochem       Date:  2010-09-14

2.  Associations between serum leptin level and bone turnover in kidney transplant recipients.

Authors:  Csaba P Kovesdy; Miklos Z Molnar; Maria E Czira; Anna Rudas; Akos Ujszaszi; Laszlo Rosivall; Miklos Szathmari; Adrian Covic; Andras Keszei; Gabriella Beko; Peter Lakatos; Janos Kosa; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

3.  Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1.

Authors:  I K Lukić; D Grcević; N Kovacić; V Katavić; S Ivcević; I Kalajzić; A Marusić
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

4.  Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma.

Authors:  A F Wisniewski; S A Lewis; D J Green; W Maslanka; H Burrell; A E Tattersfield
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

5.  Plasma osteocalcin in healthy Nigerian children and in children with calcium-deficiency rickets.

Authors:  L M Oginni; M Worsfold; C A Sharp; O A Oyelami; D E Powell; M W Davie
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

6.  Role of 1,25-dihydroxyvitamin D3 in the generation of the acute-phase response in rats with talc-induced granulomatosis.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Experientia       Date:  1993-08-15

7.  Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group.

Authors:  H A Kerstjens; D S Postma; J J van Doormaal; A K van Zanten; P L Brand; P N Dekhuijzen; G H Koëter
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

8.  Treatment of eggshell with casein phosphopeptide reduces the severity of ovariectomy-induced bone loss.

Authors:  Jung-Hoon Kim; Min Seuk Kim; Hong-Geun Oh; Hak-Yong Lee; Jeong-Woo Park; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Eun-Hye Shin; Eun-Kyeong Oh; Munkhsoyol Erkhembaatar; Okjin Kim; Yong-Rae Lee; Han-Jung Chae
Journal:  Lab Anim Res       Date:  2013-06-24

9.  Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men.

Authors:  El Hadidy M El Hadidy; Mohamed Ghonaim; Soma Sh Abd El Gawad; Mohamed Abou El Atta
Journal:  BMC Endocr Disord       Date:  2011-08-06       Impact factor: 2.763

10.  Opuntia humifusa supplementation increased bone density by regulating parathyroid hormone and osteocalcin in male growing rats.

Authors:  Junyong Kang; Jinho Park; Seong Hee Choi; Shoji Igawa; Youngju Song
Journal:  Int J Mol Sci       Date:  2012-06-04       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.